Skip to main content

Peer Review reports

From: Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma

Original Submission
10 Jun 2021 Submitted Original manuscript
20 Jul 2021 Reviewed Reviewer Report - Claudio Micheletto
11 Nov 2021 Reviewed Reviewer Report
13 Nov 2021 Author responded Author comments - Jefferson Antonio Buendía
Resubmission - Version 2
13 Nov 2021 Submitted Manuscript version 2
16 Nov 2021 Author responded Author comments - Jefferson Antonio Buendía
Resubmission - Version 3
16 Nov 2021 Submitted Manuscript version 3
20 Nov 2021 Reviewed Reviewer Report
22 Nov 2021 Reviewed Reviewer Report - Claudio Micheletto
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Nov 2021 Editorially accepted
5 Dec 2021 Article published 10.1186/s12890-021-01775-1

You can find further information about peer review here.

Back to article page